Recently added

Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation

Xu, Yan; Zhao, Yanqiu; Doucet, Ludovic; Zhou, Jianying; Wang, Yongsheng; Yang, James Chih-Hsin; FELIP, ENRIQUETA (Elsevier, 2025-05-20)

New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe

Rimassa, Lorenza; Lamarca, Angela; O'Kane, Grainne M.; Mcnamara, Mairéad; Vogel, Arndt; Edeline, Julien; Macarulla, Teresa (Elsevier, 2025-03)

TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer

O'Shaughnessy, Joyce; Cristofanilli, Massimo; Graff, Stephanie; Schmid, Peter; Oliveira, Mafalda; Im, Seock-Ah (SAGE Publications, 2025-05)

European screening platform for EORTC clinical trials in advanced colorectal cancer ‘SPECTAcolor’

Folprecht, Gunnar; Morfouace, Marie; Collienne, Maike; Salazar, Ramon; Stein, Alexander; Elez, Elena (Elsevier, 2025-06)

Spanish consensus on the diagnosis and management of adrenocortical carcinoma

Chiara, María-Dolores; Hanzu, Felicia Alexandra; Hernando, Jorge; Araujo Castro, Marta; Alvarez-Escola, Cristina; Casteràs, Anna; Carmona-Bayonas, Alberto; Giraldo Marin, Alexandra; Capdevila Castillon, Jaume (Bioscientifica, 2025-05)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation

New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe

TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer

European screening platform for EORTC clinical trials in advanced colorectal cancer ‘SPECTAcolor’

Spanish consensus on the diagnosis and management of adrenocortical carcinoma

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation ﻿

New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe ﻿

TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer ﻿

European screening platform for EORTC clinical trials in advanced colorectal cancer ‘SPECTAcolor’ ﻿

Spanish consensus on the diagnosis and management of adrenocortical carcinoma ﻿

Genetic biomarker study of sunvozertinib for clinical prognosis and prediction in NSCLC with EGFR exon 20 insertion mutation

New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe

TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer

European screening platform for EORTC clinical trials in advanced colorectal cancer ‘SPECTAcolor’

Spanish consensus on the diagnosis and management of adrenocortical carcinoma